首页> 中文期刊> 《国际检验医学杂志 》 >产生物膜的肺炎克雷伯菌的体外药敏试验探讨

产生物膜的肺炎克雷伯菌的体外药敏试验探讨

             

摘要

目的 探讨产生物膜的肺炎克雷伯菌体外药敏试验的不同,为临床治疗提供准确的药敏参考.方法 对临床分离筛选的16株产生物膜的肺炎克雷伯菌用K-B纸片扩散法进行药敏试验,记录24、48、72h这几个时间段的结果 .然后将菌株传种数代至其不产生物膜,再行上述操作.最后对两次的药敏结果 进行对比分析.结果 产生物膜的肺炎克雷伯菌24h抑菌圈的毫米数与48、72h结果 比较差异有统计学意义(P<0.05).结论 产生物膜的肺炎克雷伯菌用K-B纸片扩散法进行体外药敏试验时,结果 宜在48h后报告,这对于该菌的预防具有一定参考价值.%Objective To study the difference of in vitro drug susceptibility test of biomembrane-producing Klebsiella pneumoni-ae to provide accurate drug reference for clinical treatment.Methods The drug susceptibility test was carried out in clinically isola-ted and screened16 strains of biomembrane-producing Klebsiella pneumoniae by K-B paper diffusion method ,and the results at 24 , 48 ,72 h were recorded.Then the strains were reproduced for several generations until not producing biofilm.Then the above opera-tions were taken again.Finally ,the results of twice drug susceptibility tests were performed the contrastive analysis.Results The mm number of inhibition zone of biomembrane-producing Klebsiella pneumoniae at 24 h had statistical difference compared with that at 48 ,72 h(P<0.05).Conclusion When the in vitro drug susceptibility test of biomembrane-producing Klebsiella pneumoniae is conducted by K-B paper diffusion method ,it is suitable to report the results after 48 h ,this has a certain reference value for pre-venting this bacterium.

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号